Published Work
Publications & Selected Abstracts
Explore published research from Tisch MSRCNY
Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies
Front. Immunol., 04 August 2022. Alfonso-Dunn R, Lin J, Kirschner V, Lei J, Feuer G, Malin M, Liu J, Roche M, Sadiq SA.
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study
Front Immunol. 2023 Jun 28;14:1194671. Alfonso-Dunn R, Lin J, Lei J, Liu J, Roche M, De Oliveira A, Raisingani A, Kumar A, Kirschner V, Feuer G, Malin M, Sadiq SA.
Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis
Arch Neurol. 2008;65(2):232–235.Chowdhury SA, Lin J, Sadiq SA.
Specific electron transport chain abnormalities in amyotrophic lateral sclerosis
J Neurol. 2009 May;256(5):774-82. Lin J, Diamanduros A, Chowdhury SA, Scelsa S, Latov N, Sadiq SA.
Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab
J Neuroimmunol. 2013 Aug 15;261(1-2):123-8. Lin J, Bettin P, Lee JK, Ho JK, Sadiq SA.
Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies
Front Immunol. 2022 Aug 5;13:926318. Alfonso-Dunn R, Lin J, Kirschner V, Lei J, Feuer G, Malin M, Liu J, Roche M, Sadiq SA. Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies.
Impaired Myelination in Multiple Sclerosis Organoids: p21 Links Oligodendrocyte Dysfunction to Disease Subtype
bioRxiv 2025.01.08.631924. Nicolas Daviaud, Tanmay Mehta, William Holzman, Annie McDermott, Saud A Sadiq.
Cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defect
Biol Open. 2023 Mar 15;12(3):bio059845. Daviaud N, Chen E, Edwards T, Sadiq SA.
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulator
Proc. Natl. Acad. Sci. U.S.A. 122 (13) e2422172122. T.P. Molitor,G. Hayashi,M. Lin,C.J. Dunn,N.G. Peterson,R.G. Poston,M.P. Kurnellas,D.A. Traver,S. Patel,Z. Akgungor,V. Leonardi,C. Lewis,J.S. Segales,D.S. Bennett,A.P. Truong,M. Dani,S. Naphade,J.K. Wong,A.E. McDermott,[...]& A. Rassoulpour
Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis
Brain Communications, Volume 4, Issue 4, 2022. Jamie K Wong, Anna K Roselle, Taylor M Shue, Serena J E Shimshak, Joseph M Beaty, Nadia M Celestin, Ivy Gao, Rose P Griffin, Merit E Cudkowicz, Saud A Sadiq.
Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic
Brain, Volume 146, Issue 5, May 2023. Jamie K Wong, Jerry Lin, Nathan J Kung, Alexandra L Tse, Serena J E Shimshak, Anna K Roselle, Francesca M Cali, Jessie Huang, Joseph M Beaty, Taylor M Shue, Saud A Sadiq.
Mesenchymal stem cell-derived neural progenitors in progressive MS
Neurol Neuroimmunol Neuroinflamm. 2020 Dec 4;8(1):e928. Harris VK, Stark JW, Yang S, Zanker S, Tuddenham J, Sadiq SA.
Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis
PLoS One. 2023 Aug 11;18(8):e0290069. Harris VK, Wollowitz J, Greenwald J, Carlson AL, Sadiq SA.
Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making
Mol Diagn Ther. 2009;13(4):225-44. Harris VK, Sadiq SA.
Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis
Neurobiol Dis. 2010 Oct;40(1):331-9. Harris VK, Diamanduros A, Good P, Zakin E, Chalivendra V, Sadiq SA.
Mesenchymal Stem Cells Enhance the Engraftment and Myelinating Ability of Allogeneic Oligodendrocyte Progenitors in Dysmyelinated Mice
Stem Cells Dev. 2011 Dec;20(12):2065-76. Cristofanilli M, Harris VK, Zigelbaum A, Goossens AM, Lu A, Rosenthal H, Sadiq SA.
Clinical and Pathological Effects of Intrathecal Injection of Mesenchymal Stem Cell-Derived Neural Progenitors in an Experimental Model of Multiple Sclerosis
J Neurol Sci. 2012 Feb 15;313(1-2):167-77. Harris VK, Yan QJ, Vyshkina T, Sahabi S, Liu X, Sadiq SA.
Characterization of Autologous Mesenchymal Stem Cell-Derived Neural Progenitors as a Feasible Source of Stem Cells for Central Nervous System Applications in Multiple Sclerosis
Stem Cells Transl Med. 2012 Jul;1(7):536-47. Harris VK, Faroqui R, Vyshkina T, Sadiq SA.
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status
Mol Diagn Ther. 2014 Dec;18(6):605-17. Harris VK, Sadiq SA.
